MoonLake Immunotherapeuti Correlations
MLTX Stock | USD 54.17 0.15 0.28% |
The current 90-days correlation between MoonLake Immunotherapeuti and Structure Therapeutics American is 0.22 (i.e., Modest diversification). The correlation of MoonLake Immunotherapeuti is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
MoonLake Immunotherapeuti Correlation With Market
Very weak diversification
The correlation between MoonLake Immunotherapeutics and DJI is 0.51 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MoonLake Immunotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
MoonLake |
Moving against MoonLake Stock
0.48 | EQ | Equillium | PairCorr |
0.47 | BACK | IMAC Holdings | PairCorr |
0.45 | VALN | Valneva SE ADR | PairCorr |
0.35 | TCHH | Trustcash Holdings | PairCorr |
0.33 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.34 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MoonLake Stock performing well and MoonLake Immunotherapeuti Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MoonLake Immunotherapeuti's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TERN | 3.37 | (0.37) | 0.00 | (3.71) | 0.00 | 5.68 | 34.09 | |||
DAWN | 2.09 | (0.15) | 0.00 | (0.07) | 0.00 | 3.84 | 11.44 | |||
ABOS | 3.49 | (0.56) | 0.00 | (0.08) | 0.00 | 7.52 | 28.07 | |||
AMLX | 4.31 | 1.40 | 0.29 | 1.18 | 4.02 | 10.06 | 33.56 | |||
AVTE | 2.53 | 0.48 | 0.18 | 0.60 | 2.13 | 5.58 | 19.11 | |||
ELVN | 1.89 | 0.02 | 0.01 | 0.13 | 2.04 | 5.84 | 12.96 | |||
GPCR | 2.96 | (0.25) | 0.00 | (0.23) | 0.00 | 8.18 | 24.50 | |||
CMPX | 4.18 | 0.02 | 0.06 | 0.12 | 4.50 | 11.19 | 29.38 | |||
VTYX | 3.06 | (0.36) | 0.00 | (0.03) | 0.00 | 6.94 | 16.88 |
MoonLake Immunotherapeuti Corporate Management
Tino Anthamatten | Market Marketing | Profile | |
Luciana Marques | People HR | Profile | |
Jorge Silva | CEO CoFounder | Profile | |
Nicolas Mosimann | General Counsel | Profile | |
Oliver Daltrop | Chief Officer | Profile |